Innate immune-related receptors in normal and psoriatic skin

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 2, 2003, Pages 178-186

  Curry, Jonathan L ^a   Qin, Jian Zhong ^a   Bonish, Brian ^a   Carrick, Ryan ^a   Bacon, Patricia ^a   Panella, Jeffrey ^a   Robinson, June ^a   Nickoloff, Brian J ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CELL SURFACE RECEPTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; RECEPTOR; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTATION; ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MACROPHAGE; PSORIASIS; SKIN;

ANTIGENS, CD14; CELL DIVISION; CELLS, CULTURED; CHAPERONIN 60; DENDRITIC CELLS; DERMIS; DROSOPHILA PROTEINS; EPIDERMIS; FIBROBLASTS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNITY, NATURAL; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; LDL-RECEPTOR RELATED PROTEINS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; PSORIASIS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SKIN; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 0037326549     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Bowcock AM, Shannon W, Du F, et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet. 2001;10:1793-1805.
2. Travers JB, Hamid QA, Norris DA, et al. Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis. J Clin Invest. 1999;104:1181-1189.
3. Aractingi S, Briand N, Le Danff C, et al. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol. 2001;159:71-77.
4. Nickoloff BJ. Skin innate immune system in psoriasis: friend or foe? J Clin Invest. 1999;104:1161-1164.
5. Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol. 1991;127:871-884.
6. Heldwein K, Golenbock D, Fenton M. Recent advances in the biology of Toll-like receptors. Mod Asp Immunobiol. 2001;1:249-252.
7. Kaisho T, Akira S. Critical roles of Toll-like receptors in host defense. Crit Rev Immunol. 2000;20:393-405.
8. Imfer JL, Hoffmann JA. Toll receptors in innate immunity. Trends Cell Biol. 2001;11:304-311.
9. Shimazu R, Akashi S, Ogata H, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med. 1999;189:1777-1782.
10. Gandour-Edwards R, McClaren M, Isseroff RR. Immunolocalization of low-molecular-weight stress protein HSP 27 in normal skin and common cutaneous lesions. Am J Dermatopathol. 1994;16:504-509.
11. Maytin EV. Differential effects of heat shock and UVB light upon stress protein expression in epidermal keratinocytes. J Biol Chem. 1992;267:23189-23196.
12. DeNagel DC, Pierce SK. A case for chaperones in antigen processing. Immunol Today. 1992;13:86-89.
13. Asea A, Kraeft SK, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6:435-442.
14. Binder RJ, Karimeddini D, Srivastava PK. Adjuvanticity of alpha 2-macroglobulin, an independent ligand for the heat shock protein receptor CD91. J Immunol. 2001;166:4968-4672.
15. Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity. 2001;14:303-313.
16. Rosenberg EW, Noah PW. The Koebner phenomenon and the microbial basis of psoriasis. J Am Acad Dermatol. 1988;18:151-158.
17. Shi F, Ljunggren HG, Sarvetnick N. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol. 2001;22:97-101.
18. Nickoloff BJ, Denning M. Sensing and killing bacteria in skin: innate immune defense system: good and bad news. J Invest Dermatol. 2001;117:2, 170.
19. Novak N, Bieber T. The skin as a target for allergic diseases. Allergy. 2000;55:103-107.
20. Saiag P, Coulomb B, Lebreton C, Bell E, Dubertret L. Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science. 1985;230:669-672.
21. Nestle FO, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells in psoriasis: autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest. 1994;94:202-209.
22. Qin JZ, Bacon P, Chaturvedi V, Nickoloff BJ. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand. J Invest Dermatol. 2001;117:898-907.
23. Qin JZ, Chaturvedi V, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. Role of NF-κB in the apoptotic-resistant phenotype of keratinocytes. J Biol Chem. 1999;274:37957-37964.
24. Chen B, Stiff P, Sloan G, et al. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli. Clin Immunol. 2001;98:280-292.
25. Gutierrez-Steil C, Wrone-Smith T, Sun X, Krueger JG, Coven T, Nickoloff BJ. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest. 1998;101:33-39.
26. Miettinen M, Sareneva T, Julkunen I, Matikainen S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2001;2:349-355.
27. Tabeta K, Yamazaki K, Akashi S, et al. Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun. 2000;68:3731-3735.
28. Faure E, Equils O, Sieling PA, et al. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells: differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem. 2000;275:11058-11063.
29. Rasmussen HH, Celis JE. Evidence for an altered protein kinase C (PKC) signaling pathway in psoriasis. J Invest Dermatol. 1993;101:560-566.
30. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ. Keratinocytes as initiators of inflammation. Lancet. 1991;337:211-214.
31. Ghadially R, Reed JT, Elias PM. Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 1996;107:558-564.
32. Singer KH, Tuck DT, Sampson HA, Hall RP. Epidermal keratinocytes express the adhesion molecule intercellular adhesion molecule-1 in inflammatory dermatoses. J Invest Dermatol. 1989;92:746-750.
33. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992;90:482-487.
34. Teraki Y, Moriya N, Shiohara T. Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption. Am J Pathol. 1994;145:550-560.
35. Nickoloff BJ, Turka LA. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today. 1994;15:464-469.
36. Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med. 2002;8:157-165.
37. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000;68:7010-7017.
38. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol. 2001;167:1609-1616.
39. Asai Y, Ohyama Y, Gen K, Ogawa T. Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect Immun. 2001;69:7387-7395.
40. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol. 2002;168:2424-2432.
41. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol. 2001;166:249-255.
42. Bulut Y, Faure E, Thomas L, et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol. 2002;168:1435-1440.
43. Menoret A, Chandawarkar R. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come. Semin Oncol. 1998;25:654-660.
44. Kumamoto T, Huang EK, Paek HJ, et al. Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat Biotechnol. 2002;20:64-69.
45. Aiba S, Terunuma A, Manome H, Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol. 1997;27:3031-3038.
46. Fraki JE, Briggaman RA, Lazarus GS. Transplantation of psoriatic skin onto nude mice. J Invest Dermatol. 1983;80(suppl):31s-35s.
47. Van de Kerkhof PC, Gerritsen MJ, de Jong EM. Transition from symptomless to lesional psoriatic skin. Clin Exp Dermatol. 1996;21:325-329.
48. Medzhitov R, Janeway CA Jr. An ancient system of host defense. Curr Opin Immunol. 1998;10:12-15.
49. Rosenberg EW, Noah PW, Skinner RB Jr. Psoriasis is a visible manifestation of the skin's defense against micro-organisms. J Dermatol. 1994;21:375-381.
50. Kobayashi K, Inohara N, Hernandez LD, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 2002;416:194-199.